viral Flashcards

1
Q

basic virus structure

A

DNA or RNA forms the core, which is surrounded by a
protein coat.

Protein coat or capsid comprises protein units or
capsomeres

•Together the nucleic acid core and capsid form the
nucleocapsid

•In some viruses, the nucleocapsid is surrounded by an

  • *envelope, a lipid bilayer of host cell origin**.
  • envelope is studded with virus-encoded glycoproteins.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

‘spikes’ in the viral envelope

A

attach virus to cell surface
mediate virus entry into cells
targets for antibodies

has carbohydrate side chain & transmembrane anchor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

viral life cycle

A

extracellular phase in which virus particle
(“virion”) is metabolically inert and
intracellular phase in which virus genome
expression occurs
; this, together with
involvement of host proteins (animal, plant or bacteria)
and other host functions, achieves production of
new progeny virions.

Viruses are obligate intracellular pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

enveloped vs nonenveloped

A

Non-enveloped “naked” viruses tend to survive well
(& may be bile resistant)
– e.g_. picorna (polio; hepatitis A) norovirus_

Enveloped viruses often survive transiently outside
host
. Spread by close or intimate contact
– e.g_. Influenza, HIV, Hepatitis B virus_

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

virus classification criteria

A
  1. Type of nucleic acid (DNA or RNA).
  2. Symmetry of nucleocapsid
  3. Lipid envelope (presence or absence).
  4. Number of strands of nucleic acid (ss/ds) & their physical construction (e.g. segmented)
  5. Polarity of viral genome (e.g. + or - strand RNA).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DNA viruses

A

enveloped:

poxvirus

baculovirus

herpesvirus

naked:

adenovirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

viral replication steps

A
  1. Attachment - to susceptible target cells
  2. Penetration - to cell interior (traverse membrane)
  3. Uncoating - primes for transcription
  4. Transcription - production of viral RNA
    * *5. Translation** - viral proteins produced
  5. Replication - DNA or RNA, driven by viral proteins
  6. Assembly - new virions formed
  7. Release - & dissemination or transmission

key point: many critical functions and activities
are provided by the infected hos cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how DNA virus replicates its genome

A

DNA viruses with large genomes e.g. poxviruses, herpesviruses encode 100 or more genes, including many of the enzymes required for genomic
replication (e.g. DNA polymerase) and are
more “autonomous”

DNA Viruses with small genomes e.g. papillomaviruses
encode only a few genes and use the host cell DNA polymerase etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how RNA viruses replicate

A

Most RNA viruses encode their own
RNA-dependent RNA polymerase
,
which uses complementary RNA as template

  • *Retroviruses (& DNA Hepadnaviruses) ** encode Reverse Transcriptase - RNA-dependent DNA polymerase =>
  • make dsDNA from RNA, for new genome synthesis

RNA dependent polymerases lack proofreading ability,
→ RNA viruses mutate quickly (& often replicate faster)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

PLUS-STRAND RNA

A

Positive-stranded RNA is:

equivalent to mRNA and can often be immediately translated into proteins once the viral genome gains entry into the cytoplasm.

Therefore, protein synthesis is the first step, and
_one of the proteins synthesized is the viral
polymerase.
_The _polymerase then synthesizes
a *negative-strand copy of the +veRNA*, which is
then copied back into +veRNA messages.
_

Translation of these messages produces
structural proteins that are used to package
progeny +veRNA into virions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MINUS-STRAND RNA

A

Negative-stranded RNA:

must first be converted into +veRNA (mRNA) by the RNA-dependent RNA polymerase (RDRP) incorporated in the virion.

The mRNA can then be translated into proteins.

Replicative enzymes (RDRP) synthesize a negative-strand copy of the +veRNA.

Structural proteins translated from the mRNA are
then used to package progeny -veRNA and RDRP into virions.

These types of viruses must package a polymerase into the viral capsid, because cells lack enzymes that will make a +veRNA copy of the viral -veRNA strand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

outcome after viral infection of cell

A
  • *• Clearance** following acute phase of cell death
    e. g. influenza, viral gastroenteritis, poliovirus, measles

Persistent infection with continued production of infectious virus and immune evasion
e.g. hepatitis B, HIV

Latent infection with virus persistence after initial clearance, and asymptomatic or symptomatic reactivation
e.g. Herpes viruses – herpes simplex, varicella zoster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

latent virus infections

A

Viral DNA persists but does not replicate to
produce new infectious virus

• May never cause signs of disease.
• May activate on one or more occasions, and be
asymptomatic or cause disease.
• Some latent infections may lead to malignant
disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

exposure

A

potential physical contact with virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

tropism

A

which cells/tissues (or host) are susceptible?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

virulence

A

capacity to cause disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

VIral pathogenesis mechanisms

A

Cell death:

  • Lytic infection, apoptosis,
  • Immune mediated e.g. AIDS is attributable to the progressive loss of helper T cells

Interference with cellular function
hepatitis, myocarditis, neuralgia

Body’s response to cell damage
– INCREASED mucous production in respiratory tract infections

Cell transformation and oncogenesis

Local effects of the immune response
– swelling, congestion, arthropathy, rashes

Systemic effects of the immune response
– fever

Immunosuppression
– Cytomegalovirus
– Measles

Triggering autoimmune response
post-infectious encephalomyelitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Defence:

Innate mechanisms

A

macrophages, neutrophils, NK, complement, interferon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

defence: antibodies do what?

A

neutralise further spread

20
Q

Viral mechanisms of Immune Evasion
Interference with cytokine network

A

mimic cytokine receptors - poxviruses

mimic inhibitory cytokines - EBV

inhibit interferon - adenovaccinia, influenza

suppress m-derived cytokines- measles

21
Q

immune escape - antigen variation

A

mutation of epitopes RNA viruses > DNA viruses

antigenic “shift”/reassortment : influenza virus

22
Q

ECLIPSE PHASE

A

Period from virus entry until new infectious virions released

23
Q

INCUBATION PERIOD

A

Interval between exposure and appearance of rash/sign

24
Q

PRODROME

A

Non-specific symptoms appearing before more specific features (usually rash)

25
REPRODUCTIVE NO R0 INFECTIOUSNESS
Average number of secondary cases arising from a single index case in a totally susceptible population
26
family HERPESVIRIDAE
_Structure_ • Members share common architecture → morphologically identical under EM • **Large double-stranded DNA genome** – EBV 162 kB; CMV 360 kB • **Icosahedral capsid** • **Lipid envelope** derived from host cell bearing virus-encoded glycoproteins *Over 100 herpesviruses have been identified* • Biological properties and genomic structure **Sub-families alpha-, beta-, gamma- herpesvirinae** • Viruses of each species are **numbered in chronological order of discovery** • **Eight human herpes viruses** have been identified to date
27
Herpesviruses species
_Alphaherpesvirinae:_ Herpes simplex virus type 1 HSV-1 Herpes simplex virus type 2 HSV-2 **Varicella zoster virus VZV** _Betaherpesvirinae_ **Cytomegalovirus CMV** Human herpesvirus 6 HHV-6 Human herpesvirus 7 HHV-7 _Gammaherpesvirinae_ **Epstein-Barr virus EBV** Human herpes virus 8 HHV-8
28
natural history of herpes v infections
• Primary infections are frequently asymptomatic • Virus is not cleared but persists in a latent state • Reactivation may be clinical or sub-clinical • Infection is usually widespread in the natural host
29
Seropositive status indicates\_\_\_\_
infection, not immunity
30
antiviral agents do what against herpes viruses?
e.g. Aciclovir, Ganciclovir can control productive herpes virus infections but cannot eradicate/control latent infection
31
what does varicella zoster virus do?
• Primary infection causes chickenpox (varicella) • Latent in dorsal root or cranial nerve ganglia • Reactivation causes shingles (zoster) • During reactivation virus travels down sensory nerves and produce painful vesicles in the area of skin served by infected ganglion
32
P{rimary VZV infection
Peak incidence in early childhood • O**nly 5% over 18’s remain susceptible in temperate zones** • **50% over 24 year olds in the tropics are susceptible** • Incidence of varicella high in susceptible visitors to temperate zones
33
varicella clinical features
• **Incubation period 10-21d** • Asymptomatic infection uncommon • Prodromal symptoms: fever, pharyngitis, malaise • Itchy/painful lesions appear in crops • **Macule →papule → vesicle → pustule → crusts** • More severe in adults / immunocompromised • Varicella vaccine is licensed for routine childhood immunisation in the USA
34
varicella complications
_Children_ **Acute cerebellar ataxia** - 1:4000 cases (15y) _Adults_ **Pneumonia** - 1:400 cases \> hospital admission
35
Zoster
Common condition • **Reactivation of latent VZV** • Pain at site may precede eruption of painful vesicles • **Unilateral; 1-2 dermatomes involved** • _**Ophthalmic division of trigeminal nerve → involvement of eye in 50%**_ _• Post-herpetic neuralgia_ especially in the elderly • **Incidence increases with age** and in the i.c. host *• Immunocompetent rarely suffer at most 2 attacks decades apart during a lifetime*
36
zoster in immunocompromised host
More severe, extensive, prolonged rash. Risk of disseminated infection 6-10 days after onset of localised rash - cutaneous - visceral pneumonitis; hepatitis; meningoencephalitis
37
VZV horicontal transmission
• Varicella is spread by respiratory route, commencing 48h before onset of rash. • Skin lesions of varicella and zoster are infectious until crusted over.
38
VZV vertical transmission
**Congenital Varicella** _Maternal varicella in the first 20 weeks of gestation_ results in foetal defects in \<2% of cases. *Maternal shingles does not damage the foetus* **Neonatal Varicella** _Maternal varicella occurring within 7 days before or 7 days after delivery_is associated with a **high mortality in the newborn infant**
39
Post-exposure prophylaxis
Varicella zoster hyperimmune globulin - VZIG Indicated for susceptible individuals at risk of severe VZV infection following a significant exposure incident • Pregnant • Immunosuppressed • Neonate of seronegative mother
40
VZV antiviral therapy?
• Not routine in uncomplicated childhood varicella • Advised for varicella in adults and in immunocompromised individuals • Recommended for treatment of zoster • Ophthalmic zoster: mandatory ophthalmological assessment
41
VZV first line treatment
Aciclovir po or iv Valaciclovir po • Famciclovir po These are also the first line agents for HSV, but as VZV is less susceptible, higher doses are required
42
Oka varicella vaccine
• Live attenuated vaccine • Part of routine childhood vaccination schedule in USA • 2 dose schedule • Recommended in UK for – susceptible healthcare workers – Susceptible household contacts of immunocompromised patients
43
Viruses in general often interfere with immune system processes HIV EBV HSV
1. HIV overwhelmingly most important 2. U**ses CD4 molecule to invade host cell** : T-cells, also macrophages and glial cells 3. Also uses chemokine receptors **CCR5/ CXCR4** 4. Decline in CD4+ cell numbers inexorable whilst virus proliferates 5. Major defects in immunity follow loss of CD4 T cells: **Lower IL-2, INF, B cell growth factors** _Epstein Barr virus (EBV_) : **infects B cells and causes random proliferation** _Herpes simplex virus (HSV_): d**own-regulates MHC in the cells it infects**
44
retrovirus
enveloped RNA ss+ icosahedral
45
orthomyxovirus
enveloped RNA ss- helical
46
herpesvirus
enveloped DNA ds icosohedral
47
DNA viruses
1. poxoviridae 2. herpesviridae 3. adenoviridae 4. hepadenaviridae 5. papovaviridae 6. parvoviridae